Using differential display PCR, we have identified a gene [NOEY2, ARHI (des
ignation by the Human Gene Nomenclature Committee)] with high homology to r
as and rap that is expressed consistently in normal ovarian and breast epit
helial cells but not in ovarian and breast cancers. Reexpression of NOEY2 t
hrough transfection suppresses clonogenic growth of breast and ovarian canc
er cells. Growth suppression was associated with down-regulation of the cyc
lin DI promoter activity and induction of p21(WAF1/CIP1). In an effort to i
dentify mechanisms leading to NOEY2 silencing in cancer, we found that the
gene is expressed monoallelically and is imprinted maternally. Loss of hete
rozygosity of the gene was detected in 41% of ovarian and breast cancers. I
n most of cancer samples with loss of heterozygosity, the non-imprinted fun
ctional allele was deleted. Thus, NOEY2 appears to be a putative imprinted
tumor suppressor gene whose function is abrogated in ovarian and breast can
cers.